Utang jangka cendhak marang modal: Revvity Inc (RVTY)

Tandha merek Revvity, Inc. (RVTY)

The short-term debt-to-equity structure dynamics for Revvity, Inc. (RVTY) on GURU.Markets include the 0.03 indicator, established as the baseline value. Jangi Nazaryan's team has successfully pivoted the company toward profitable diagnostics segments. Rising share prices are driving the divestment of non-core assets and a recovery in demand from the biotechnology sector. Business resilience is underpinned by recurring consumable sales and the R&D investment volumes of pharmaceutical behemoths.

RVTY - Utang jangka cendhak marang modal PerkinElmer ing rentang 21.02.2024 - 29.10.2026
Produk merek Revvity

For Revvity, Inc., a provider of high-tech genomics and diagnostics solutions, the share of short-term loans in the company's equity reflects the degree of reliance on operational borrowing. This metric compares liabilities with a maturity of up to one year against total equity. Such a calculation reveals the balance sheet's vulnerability to sudden rate hikes or a credit crunch. A consistently low level of this indicator confirms financial stability and investment security.

Pesaing Revvity, Inc. (RVTY)

Utang jangka cendhak marang modal A|DGX - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal ILMN (Illumina, Inc.)|EXAS: Rasio utang jangka cendhak marang modal|Bio-Rad - Utang jangka cendhak marang modal|NNNN - Utang jangka cendhak marang modal|Sterigenics (SHC) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal QDEL|OPK (OPKO Health, Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal CareDx Corp|Utang jangka cendhak marang ekuitas Maravai LifeSciences Holdings, Inc. (MRVI)|Utang jangka cendhak marang ekuitas FLGT (Fulgent Genetics Inc)|Fluidigm - Rasio utang jangka cendhak marang ekuitas|Cytek Corp (CTKB) - Kewajiban jangka cendhak marang modal|OSUR - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Exagen Inc. XGN|MDXH: Utang jangka cendhak marang modal|LUCD - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Prenetics Global Limited|Insight Molecular (IMDX) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Trinity Biotech plc (TRIB)|PRPH (prophaselabs.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal AIMD (Ainos)|Co-Diagnostics Inc (CODX) - Kewajiban jangka cendhak marang modal|HSCS: Rasio utang jangka cendhak marang ekuitas|BMRA: Utang jangka cendhak marang ekuitas|CDIO (cardiodiagnosticsinc.com) - Rasio utang jangka cendhak marang ekuitas|VRAX (viraxbiolabs.com) - Utang jangka cendhak marang ekuitas|BJDX (Bluejay Diagnostics, Inc.) - Utang jangka cendhak marang modal|Aspira Women's Health, Inc. (AWH) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas AXDX (Accelerate Diagnostics, Inc)|Rasio silihan jangka cendhak marang modal CNTG|Enzo Biochem - Rasio utang jangka cendhak marang ekuitas|Fresh2 Group Ltd (FRES) - Kewajiban jangka cendhak marang modal|GENE: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ME (23andMe Holding Co)|PMD: Utang jangka cendhak marang modal